Crossmark

Rapid detection of invasive Mycobacterium chimaera disease via a novel plasma-based next-generation sequencing test

Crossref DOI link: https://doi.org/10.1186/s12879-019-4001-8

Published Online: 2019-05-02

Published Print: 2019-12

Update policy: https://doi.org/10.1007/springer_crossmark_policy

Authors

Nomura, Jim https://orcid.org/0000-0001-5224-6262
Rieg, Gunter

Bluestone, Gary

Tsai, Townson

Lai, Andrew

Terashita, Dawn

Bercovici, Sivan

Hong, David K.

Lee, Brian P.
License Information

Text and Data Mining valid from 2019-05-02
More Information

Article History

Received: 19 September 2018

Accepted: 17 April 2019

First Online: 2 May 2019

Ethics approval and consent to participate

: This retrospective case series was approved by the Institutional Review Board of Kaiser Permanente. The IRB did not require patient consent for this study.

: Written consent to publish was obtained from patient 1 (illustrative case).

: D.K.H. and S.B. are employees of Karius, Inc. B.P.L. is a consultant for and previous employee of Karius, Inc. All other authors report no potential conflicts.

: Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.